Display Settings:

Format

Send to:

Choose Destination

    Nat Med. 2009 Mar;15(3):277-84. Epub 2009 Feb 22.

    Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10.

    Sun J, Madan R, Karp CL, Braciale TJ.

    Beirne B. Carter Center for Immunology Research, University of Virginia, 409 Lane Road, Charlottesville, Virginia 22908, USA.

    Activated antigen-specific T cells produce a variety of effector molecules for clearing infection but also contribute to inflammation and tissue injury. Here we report an anti-inflammatory property of antiviral CD8+ and CD4+ effector T cells (T(eff) cells) in the infected periphery during acute virus infection. We find that, during acute influenza infection, interleukin-10 (IL-10) is produced in the infected lungs in large amounts--exclusively by infiltrating virus-specific T(eff) cells, with CD8+ T(eff) cells contributing a larger fraction of the IL-10 produced. These T(eff) cells in the periphery simultaneously produce IL-10 and proinflammatory cytokines and express lineage markers characteristic of conventional T helper type 1 or T cytotoxic type 1 cells. Notably, blocking the action of the T(eff) cell-derived IL-10 results in enhanced pulmonary inflammation and lethal injury. Our results show that antiviral T(eff) cells exert regulatory functions--that is, they fine-tune the extent of lung inflammation and injury associated with influenza infection by producing an anti-inflammatory cytokine. We discuss the potential implications of these findings for infection with highly pathogenic influenza viruses.

    PMID: 19234462 [PubMed - indexed for MEDLINE]

    PMCID: 2693210

    Publication Types, MeSH Terms, Substances, Grant Support

    Supplemental Content

    Click here to read Click here to read